Orthofix Announces New President for Bone Growth Therapies Business

LEWISVILLE, Texas, February 29, 2024 –(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a number one international spine and orthopedics firm, right now introduced the appointment of Jason Shallenberger to President of the Bone Progress Therapies enterprise, and the realignment of its Backbone enterprise unit, efficient March 1. A seasoned gross sales chief, Shallenberger beforehand served as Vice President of U.S. Gross sales and Advertising for the Orthofix Bone Progress Therapies enterprise.

Previous to this realignment, the Bone Progress Therapies enterprise was managed underneath the management of the Firm’s Backbone enterprise unit. Bone Progress Therapies and Backbone will now be led by separate Presidents in alignment with the Firm’s present enterprise buildings for Biologics and Enabling Applied sciences.

“Jason has led gross sales and advertising and marketing for this profitable franchise for quite a few years,” mentioned Massimo Calafiore, President and Chief Govt Officer of Orthofix. “Underneath his steerage, the gross sales workforce has produced quarter-after-quarter of double-digit development in 2023. I’m assured he’ll do a tremendous job as President and proceed to contribute significantly to the success of Orthofix.”

“Since 1986, Orthofix Bone Progress Remedy has helped promote the natural-bone therapeutic course of in sufferers,” mentioned Shallenberger. “I’m honored to proceed my profession with the corporate on this new position as we proceed to innovate and convey new applied sciences to the market.”

Shallenberger joined Orthofix in 2005 as a Territory Supervisor and shortly moved into the position of District Gross sales Supervisor earlier than being promoted to the place of Regional Gross sales Director in 2008. He was promoted to Vice President of U.S. Gross sales and Advertising in 2011 and led his workforce to 30 consecutive quarters of year-over-year development, outpacing annual market development charges, and was given further duties for medical schooling in 2023. Previous to becoming a member of Orthofix, Shallenberger labored as a specialty gross sales consultant with Boehringer Ingelheim Prescribed drugs. He’s a graduate of the College of Nebraska.

About Bone Progress Therapies

Orthofix bone development remedy units present a protected, noninvasive therapy that helps fractured bones and spinal fusions that haven’t healed or have issue therapeutic. The units stimulate the bone’s pure therapeutic course of by sending low-level pulses of electromagnetic power or pulse ultrasound to the injury or nonunion website. The market chief within the bone development stimulation house, greater than one million sufferers have been handled with Orthofix’s Pulsed Electromagnetic Area Stimulation (PEMF) units. In 2022 Orthofix launched the AccelStim^™ gadget with Low-Depth Pulsed Ultrasound (LIPUS) expertise, a nonsurgical therapy for indicated contemporary fractures and for fractures that haven’t healed (nonunions). This method is part the portfolio of PEMF units consisting of the SpinalStim^™, CervicalStim^™ and PhysioStim^™ programs. To study extra about bone development therapies go to bonegrowththerapy.com.

Orthofix is a number one international spine and orthopedics firm with a complete portfolio of biologics, revolutionary spinal {hardware}, bone development therapies, specialised orthopedic options, and a number one surgical navigation system. Its merchandise are distributed in additional than 60 nations worldwide.

The Firm is headquartered in Lewisville, Texas, the place it conducts common enterprise, product improvement, medical schooling and manufacturing, and has major workplaces in Carlsbad, CA, with a deal with spine and biologics product innovation and surgeon schooling, and Verona, Italy, with an emphasis on product innovation, manufacturing, and medical schooling for orthopedics. The mixed Firm’s international R&D, business and manufacturing footprint additionally consists of services and workplaces in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Department, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.

Ahead-Wanting Statements

This information launch could embody forward-looking statements throughout the which means of Part 21E of the Securities Trade Act of 1934, as amended, and Part 27A of the Securities Act of 1933, as amended. In some instances, you possibly can establish forward-looking statements by terminology resembling “could,” “will,” “ought to,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “tasks,” “intends,” “predicts,” “potential,” “proceed” or different comparable terminology. Orthofix cautions you that statements included on this information launch that aren’t an outline of historic details are forward-looking statements which can be primarily based on the Firm’s present expectations and assumptions. Every forward-looking assertion contained on this information launch is topic to dangers and uncertainties that might trigger precise outcomes to vary materially from these expressed or implied by such assertion. Relevant dangers and uncertainties embody, amongst others: the flexibility of newly launched merchandise to carry out as designed and supposed and to fulfill the wants of surgeons and sufferers, together with because of the dearth of sturdy scientific validation; and the dangers recognized underneath the heading “Threat Components” in Orthofix Medical Inc.’s Annual Report on Kind 10-Okay for the fiscal yr ended December 31, 2022, which was filed with the Securities and Trade Fee (SEC) on March 6, 2023. The Firm’s public filings with the Securities and Trade Fee can be found at www.sec.gov. You might be cautioned to not place undue reliance on forward-looking statements, which converse solely as of the date when made. Orthofix doesn’t intend to revise or replace any forward-looking assertion set forth on this information launch to mirror occasions or circumstances arising after the date hereof, besides as could also be required by legislation.